NCT06225921 2024-03-06
Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas
West China Hospital
Phase 1 Unknown
Clinical Trials
3 trialsNCT05515289 2023-03-10
Study of SHR6390 in Renal Insufficiency and Healthy Subjects
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT05586841 2022-10-19
Exploration of Dalpiciclib + Chidamide in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor: a Phase â… b Study
Beijing 302 Hospital
Phase 1 Unknown